Investigación / Grupos de investigación

Grupo  3

Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Publicaciones (589)

  • Fernandez, CM; Carrasco, NG; Ribelles, AJ; Muniz, NH; Gonzalez, AE; San Simon, AR; Portellano, LC; Medina, SR; Morales, CV.

    Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time

    CLINICAL & TRANSLATIONAL ONCOLOGY. 2022; 24(12): 2475-2479 [doi:10.1007/s12094-022-02912-w]

  • Buenestado-Serrano S; Recio R; Sola Campoy PJ; Catalán P; Folgueira MD; Villa J; Muñoz Gallego I; de la Cueva VM; Meléndez MA; Andrés Zayas C; Losa-García JE; Goyanes MJ; Fraile Torres A; Von Wermitz A; Fradejas-Villajos I; Del Arco C; Campelo-Gutiérrez C; González Bodi S; López-Wolf D; Iglesias-Franco H; Pérez-Lago L; Arce Arnaez A; Rodriguez Baena E; Ordobas Gavin M; Muñoz P; Delgado R; Cardeñoso L; Viedma E; García de Viedma D.

    First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2022; 40(10): 546-549 Nº de citas: 9 [doi:10.1016/j.eimc.2021.02.006]

  • Villanueva-Bueno C; Collado-Borrell R; Escudero-Vilaplana V; Revuelta-Herrero JL; Marzal-Alfaro MB; González-Haba E; Arranz-Arija JÁ; Osorio S; Herranz-Alonso A; Sanjurjo-Saez M.

    A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital.

    Frontiers in Public Health. 2022; 10: 978783-978783 Nº de citas: 3 [doi:10.3389/fpubh.2022.978783]

  • Errazquin, R; Page, A; Sunol, A; Segrelles, C; Carrasco, E; Peral, J; Garrido-Aranda, A; Del Marro, S; Ortiz, J; Lorz, C; Minguillon, J; Surralles, J; Belendez, C; Alvarez, M; Balmana, J; Bravo, A; Ramirez, A; Garcia-Escudero, R.

    Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia

    ORAL ONCOLOGY. 2022; 134: Nº de citas: 5 [doi:10.1016/j.oraloncology.2022.106184]

  • García-Sancho AM; Bellei M; López-Parra M; Gritti G; Cortés M; Novelli S; Panizo C; Petrucci L; Gutiérrez A; Dlouhy I; Bastos-Oreiro M; Sancho JM; Ramírez MJ; Moraleda JM; Carrillo E; Jiménez-Ubieto AI; Jarque I; Orsucci L; García-Torres E; Montalbán C; Dodero A; Arranz R; De Las Heras N; Pascual MJ; López-Jiménez J; Spina M; Re A; De Villambrosia SG; Bobillo S; Federico M; Caballero D.

    Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study

    HAEMATOLOGICA. 2022; 107(11): 2675-2684 Nº de citas: 21 [doi:10.3324/haematol.2021.279426]

  • Rey-Bua, B; Cabrero, M; Bento, L; Montoro, J; Bastos-Oreiro, M; Parody, R; Yanez, L; Lopez-Godino, O; Zanabili, J; Herrera, P; Gutierrez, G; Perez, A; Pinana, JL; Novelli, S; Cortes, M; Sureda, AM; Caballero, D; Garcia-Sancho, AM.

    Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish Groups

    Cancers. 2022; 14(22): [doi:10.3390/cancers14225670]

  • Baron, F; Labopin, M; Tischer, J; Ciceri, F; Raiola, AM; Blaise, D; Sica, S; Vydra, J; Fanin, R; Diez-Martin, JL; Bulabois, CE; Stolzel, F; Busca, A; Jindra, P; Koc, Y; Chevallier, P; Forcade, E; Rosler, W; Passweg, J; Kulagin, A; Carella, AM; Simand, C; Bazarbachi, A; Pioltelli, P; Nagler, A; Mohty, M.

    Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia

    BONE MARROW TRANSPLANTATION. 2022; 57(11): 1657-1663 Nº de citas: 6 [doi:10.1038/s41409-022-01781-9]

  • Villapalos-García G; Zubiaur P; Rivas-Durán R; Campos-Norte P; Arévalo-Román C; Fernández-Rico M; García-Fraile Fraile L; Fernández-Campos P; Soria-Chacartegui P; Fernández de Córdoba-Oñate S; Delgado-Wicke P; Fernández-Ruiz E; González-Álvaro I; Sanz J; Abad-Santos F; de Los Santos I.

    Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity.

    Life Science Alliance. 2022; 5(10): [doi:10.26508/lsa.202201396]

  • Ruggeri, A; Galimard, JE; Labopin, M; Rafii, H; Blaise, D; Ciceri, F; Diez-Martin, JL; Cornelissen, J; Chevallier, P; Sanchez-Guijo, F; Nicholson, E; Castagna, L; Forcade, E; Kuball, J; Rovira, M; Koc, Y; Pavlu, J; Gulbas, Z; Vydra, J; Baron, F; Sanz, J; Spyridonidis, A; Savani, B; Gluckman, E; Nagler, A; Mohty, M.

    Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

    Transplantation And Cellular Therapy. 2022; 28(10): Nº de citas: 7 [doi:10.1016/j.jtct.2022.07.006]

  • de Tena, PS; Bailen, R; Oarbeascoa, G; Gomez-Centurion, I; Perez-Corral, A; Carbonell, D; Martinez-Laperche, C; Sancho, M; Bastos-Oreiro, M; Conde-Royo, D; Fernandez-Caldas, P; Munoz, C; Sabell, S; Buno, I; Anguita, J; Diez-Martin, JL; Kwon, M.

    Allogeneic CD34-selected stem cell boost as salvage treatment of life-threatening infection and severe cytopenias after CAR-T cell therapy

    TRANSFUSION. 2022; 62(10): 2143-2147 Nº de citas: 5 [doi:10.1111/trf.17071]

  • MUÑIZ, P.; ANDRES, C.; CHICANO, M.; CARBONELL, D.; BAILEN, R.; OARBEASCOA, G.; SUAREZ, J.; GOMEZ, I.; DORADO, N.; Gallardo, David; ANGUITA, J.; KWON, M.; MARTINEZ, C.; BUÑO, I..

    Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation

    Frontiers in Immunology. 2022; 13: Nº de citas: 6 [doi:10.3389/fimmu.2022.1002959]

  • Martinez-Laperche, C; Sanz-Villanueva, L; Crespo, FJD; Muniz, P; Rojas, RM; Carbonell, D; Chicano, M; Suarez-Gonzalez, J; Menarguez, J; Kwon, M; Martin, JLD; Buno, I; Oreiro, MB.

    EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment

    BMC CANCER. 2022; 22(1): Nº de citas: 10 [doi:10.1186/s12885-022-10070-z]

  • Battipaglia, G; Labopin, M; Blaise, D; Diez-Martin, JL; Bazarbachi, A; Vitek, A; Chevallier, P; Castagna, L; Grillo, G; Daguindau, E; Lopez-Jimenez, J; Koc, Y; Ruggeri, A; Nagler, A; Mohty, M.

    Impact of the Addition of Antithymocyte Globulin to Post- Transplantation Cyclophosphamide in Haploidentical Transplantation with Peripheral Blood Compared to Post-Transplantation Cyclophosphamide Alone in Acute Myelogenous Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

    Transplantation And Cellular Therapy. 2022; 28(9): Nº de citas: 12 [doi:10.1016/j.jtct.2022.06.006]

  • Huyveneers, LEP; Bruns, A; Stam, A; Ellerbroek, P; de Jong, D; Nagy, NA; Gumbs, SBH; Tesselaar, K; Bosman, K; Salgado, M; Hutter, G; Brosens, LAA; Kwon, M; Martin, JD; van der Meer, JTM; de Kort, TM; Saez-Cirion, A; zur Wiesch, JS; Boelens, JJ; Martinez-Picado, J; Kuball, JHE; Wensing, AMJ; Nijhuis, M.

    Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5 Delta 32/Delta 32 Donor Cells

    Viruses-Basel. 2022; 14(9): Nº de citas: 6 [doi:10.3390/v14092069]

  • Perez-Lago, L; Kestler, M; Sola-Campoy, PJ; Rodriguez-Grande, C; Flores-Garcia, RF; Buenestado-Serrano, S; Herranz, M; Alcala, L; Martinez-Laperche, C; Suarez-Gonzalez, J; Catalan, P; Munoz, P; de Viedma, DG; Gregorio Maranon Microbiology ID C.

    SARS-CoV-2 superinfection and reinfection with three different strains

    TRANSBOUNDARY AND EMERGING DISEASES. 2022; 69(5): 3084-3089 Nº de citas: 6 [doi:10.1111/tbed.14352]

  • Carbonell, D; Chicano, M; Cardero, AJ; Gomez-Centurion, I; Bailen, R; Oarbeascoa, G; Martinez-Senaris, D; Franco, C; Muniz, P; Anguita, J; Kwon, M; Diez-Martin, JL; Buno, I; Martinez-Laperche, C.

    FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia

    Cancers. 2022; 14(16): Nº de citas: 2 [doi:10.3390/cancers14164006]

  • Baron, F; Labopin, M; Tischer, J; Ciceri, F; Raiola, AM; Blaise, D; Sica, S; Vydra, J; Fanin, R; Stolzel, F; Busca, A; Diez-Martin, JL; Koc, Y; Nagler, A; Mohty, M.

    Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients >= 55 years of age

    AMERICAN JOURNAL OF HEMATOLOGY. 2022; 97(8): 1065-1074 Nº de citas: 7 [doi:10.1002/ajh.26627]

  • Katz, DA; Morris, JD; Chu, MP; David, KA; Thieblemont, C; Morley, NJ; Khan, SS; Viardot, A; Garcia-Sancho, AM; Rodriguez-Garcia, G; Bastos-Oreiro, M; Lee, ST; Kormany, W; Chen, YQ; Wong, HL; Anderson, AA; Katlinskaya, Y; Avilion, AA; Dai, T; Gonzalez-Barca, E.

    Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL

    LEUKEMIA & LYMPHOMA. 2022; 63(9): 2063-2073 Nº de citas: 8 [doi:10.1080/10428194.2022.2064981]